Author:
Rahmianti Nia Dyah,Rahmantyo Akbar Hani
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) has infected millions of people worldwide, which is characterized by the manifestation of symptoms from coagulopathy to disseminated intravascular coagulation (DIC). This study aimed to investigated the correlation of D-dimer with lipoproteins values in COVID-19 patients. Methods: Observational cross-sectional analysis, using secondary data from medical records, based on the sample size formula it takes 78 samples, the data analysis method uses the SPSS program version 24. Results: From the results of the study, the number of patients with a D-dimer value of less than 0.5 ug/ml was 26%. While as many as 74% patients got the value of D-dimer increased by more than 0.5 ug/ml. Triglyceride and LDL levels were not associated with changes in D-dimer values. There is a correlation between the value of D-dimer with HDL (P = 0.024). High levels of D-dimer values are associated with the severity of symptoms and a poor prognosis. Excessive inflammatory processes will initiate coagulation via the extrinsic pathway, which progresses to disseminated intravascular coagulation (DIC) due to an imbalance between coagulation and fibrinolysis. Meanwhile, high HDL values reduce the risk of thrombotic events by initiating plasmin formation and are associated with low mortality rates. Conclusion: There is a statistically significant correlation between D-dimer values and HDL lipid levels. Suggestions, further research is needed to measure the correlation of D-dimer and HDL values in acute infection with the COVID-19 virus with a larger sample.
Publisher
Universiti Putra Malaysia
Reference26 articles.
1. 1. Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus disease 2019: Review of current literatures. Jurnal Penyakit Dalam Indonesia. 2020;7(1):45–67.
2. 2. covid19.go.id. Peta Sebaran COVID-19 Nasional 2021 [Internet]; 2021 [cited 2021 July 17]. Available from: https://covid19.go.id/peta-sebaran.
3. 3. Alipoor SD, Jamaati H, Tabarsi P, Mortaz E. Immunopathogenesis of Pneumonia in COVID-19. Tanaffos. 2020;19(2):79-82.
4. 4. Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-56.e1. doi:10.5694/mja2.50674
5. 5. Robba C, Battaglini D, Pelosi P, Rocco PRM. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020;14(9):865-868. doi:10.1080/17476348.2020.1778470